Increased cerebral blood volume in HIV-positive patients detected by functional MRI

Neurology

Volumn 50, Issue 6, 1998, Pages 1821-1826

  Tracey, I ^a,b   Hamberg, L M ^a   Guimaraes, A R ^a   Hunter, G ^a   Chang, I ^a   Navia, B A ^a,c   González, R Gilberto ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN BLOOD VOLUME; BRAIN CIRCULATION; BRAIN INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0031801083     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.6.1821     Document Type: Article

References (45)

1. Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1-related neurological diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology 1994;44:1892-1900.
2. McArthur JC. HIV dementia: 10 years on. J Neurovirol 1996;2:8.
3. Navia BA, Jordan BD, Price RW. The AIDS dementia complex. I. Clinical features. Ann Neurol 1986;19:517-524.
4. Price RW, Brew B, Sidtis J, et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239:586-592.
5. Lipton SA, Gendelman HE. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995;332: 934-940.
6. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986;83:7089-7093.
7. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986;19:525-535.
8. Gabuzda DH, Ho DD, de la Monte SM, et al. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986;20:289-295.
9. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-1093.
10. Pumarola-Sune T, Navia BA, Condon-Cardo C, Cho ES, Price EW. HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol 1987;21:490-496.
11. Ketzler S, Weis S, Haug H, Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol 1990;80:92-94.
12. Wiley CA, Masliah E, Morey MM, et al. Neocortical damage during HIV infection. Ann Neurol 1991;29:651-657.
13. Everall IP, Luthert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991;337:1119-1121.
14. Masliah E, Achim CL, Ge N, et al. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992;32:321-329.
15. Rottenberg DA, Moeller JR, Strother SC, et al. The metabolic pathology of the AIDS dementia complex. Ann Neurol 1987; 22:700-706.
16. Brunetti A, Berg G, Di-Chiro G, et al. Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3′ azido 2′, 3′ dideoxythymidine (AZT, zidovudine): a PET-FDG study. J Nucl Med 1989;30:581-590.
17. van Gorp WG, Mandelkern MA, Gee M, et al. Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia. J Neuropsychiatry Clin Neurosci 1992;4:280-287.
18. Hinkin CH, van Gorp WG, Mandelkern MA, et al. Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography. J Neuropsychiatry Clin Neurosci 1995;7:180-187.
19. Schielke E, Tatsch K, Pfister HW, et al. Reduced cerebral blood flow in early stages of human immunodeficiency virus infection. Arch Neurol 1990;47:1342-1345.
20. Tran Dinh YR, Mamo H, Cervoni J, et al. Disturbances in the cerebral perfusion of human immune deficiency virus-1 seropositive asymptomatic subjects: a quantitative tomography study of 18 cases. J Nucl Med 1990;31:1601-1607.
21. Masdeu JC, Yudd A, Van Heertum RL, et al. Single-photon emission computed tomography in human immunodeficiency virus encephalopathy: a preliminary report. J Nucl Med 1991; 32:1471-1475.
22. Harris GJ, Pearlson GD, McArthur JC, Zeger S, LaFrance ND. Altered cortical blood flow in HIV-seropositive individuals with and without dementia: a single photon emission computed tomography study. AIDS 1994;8:495-499.
23. Leenders KL, Perani D, Lammertsma AA, et al. Cerebral blood flow, blood volume, and oxygen utilisation: normal values and effect of age. Brain 1990;113:27-48.
24. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14: 249-265.
25. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-299.
26. Belliveau JW, Kennedy DN, McKinstry RC, et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 1991;254:716-719.
27. Aronen HJ, Cohen MS, Belliveau JW, Fordham JA, Rosen BR. Ultrafast imaging of brain tumors. Top Magn Reson Imaging 1993;5:14-24.
28. Hamberg LM, MacFarlane R, Tasdemiroglu E, et al. Measurement of cerebrovascular changes in cats after transient ischemia using dynamic magnetic resonance imaging. Stroke 1993; 24:444-451.
29. González RG, Fischman AJ, Stern CE, et al. Functional MRI in evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism measured by 18 FDG PET. Am J Neuroradiol 1995;16:1763-1770.
30. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158:1079-1083.
31. Control Centers for Disease. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 1993; 41:1-19.
32. Zierler KT, Theoretical basis of indicator-dilution methods for measuring flow and volume. Circ Res 1962;10:393-407.
33. Rempp KA, Brix G, Wenz F, et al. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR Imaging. Radiology 1994;193:637-641.
34. Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA. Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 1992;51:585-593.
35. Rosci MA, Pigorini F, Bernabei A, et al. Methods for detecting early signs of AIDS dementia complex in asymptomatic HIV-1 infected subjects. AIDS 1992;6:1309-1316.
36. Tasdemiroglu E, MacFarlane R, Wei EP, Kontos HA, Moskowitz MA. Pial vessel caliber and cerebral blood flow become dissociated during ischemia/reperfusion in cats. Am J Physiol 1992;263:H533-H536.
37. Holman BL, Garada B, Johnson KA, et al. A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. J Nucl Med 1992;33:1312-1315.
38. Sasseville VG, Lackner AA. Neuropathogenesis of simian immunodeficiency virus infection in macaque monkeys. J Neurovirol 1997;3:1-9.
39. Dawson TM, Snyder SH. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 1994; 14:5147-5159.
40. Faraci FM, Breese KR. Nitric oxide mediates vasodilation in response to activation of N-methyl-D-aspartate receptors in brain. Circ Res 1993;72:476-480.
41. Meng W, Tobin JR, Busija DW. Glutamate-induced cerebral vasodilation is mediated by nitric oxide through N-methyl-D-aspartate receptors. Stroke 1995;26:857-863.
42. Shukla A, Dikshit M, Srimal RC. Nitric oxide modulates blood-brain barrier permeability during infections with an inactivated bacterium. Neuroreport 1995;6:1629-1632.
43. Bukrinsky MI, Nottet H, Schmidtmayerova H, et al. Regulation of nitric oxide synthase in human immunodeficiency virus type 1-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995;181:735-745.
44. Lane TE, Buchmeier MJ, Watry DD, Fox HS. Expression of inflammatory cytokines and inducible nitric oxide synthase in brains of SIV-infected rhesus monkeys: applications to HIV-induced central nervous system disease. Mol Med 1996;2:27-37.
45. Adamson DC, Wildemann B, Sasaki M, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996;274:1917-1920.